Denali Therapeutics

DNLI

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-487.34M

EBITDA$-413.71M

EBIT$-422.71M

Pre-tax Income$-512.44M

Net Income$-422.77M

Cash Equivalent$100.21M

Total Debt$48.53M

Book Value$1.35B

Book Value Per Share9.48

Return on Equity (ROE)-34.38%

Return on Assets (ROA)-30.77%

Return on Invested Capital (ROI)-34.12%

Net Profit Margin-43.94%

Current Ratio8.46

Quick Ratio8.14

Long-Term Debt / Equitynull